KR-12 Antimicrobial Peptide Origami and Implications for Tar
2026-05-07
The reviewed study presents a comprehensive analysis of KR-12, a minimal human cathelicidin-derived peptide, and its engineered variants for enhanced antimicrobial and immunomodulatory activities. By detailing structural innovations, nanoformulation, and biofilm-targeting strategies, it highlights emerging peptide-based alternatives and adjuncts to conventional antibiotics—especially in the context of drug-resistant and intracellular pathogens.
TaqI Restriction Endonuclease: Technical Guide and Workflow
2026-05-06
TaqI Restriction Endonuclease (SKU K3053) provides rapid, reliable DNA digestion for plasmid, PCR, and genomic preparations, addressing bottlenecks in time-sensitive molecular biology workflows. It is not suitable for diagnostic or clinical applications and should be exclusively used for research purposes.
Pulchinenoside B4 Inhibits NLRP3 Inflammasome in Colitis Mod
2026-05-06
The reference study demonstrates that pulchinenoside B4 (PB4) alleviates DSS-induced colitis in mice by selectively inhibiting CD1d-dependent NLRP3 inflammasome activation in macrophages, without affecting intestinal epithelial cells. These findings identify a new anti-inflammatory mechanism and highlight the CD1d/NLRP3 pathway as a promising therapeutic target for ulcerative colitis.
Pronase E Protease Mixture: Structural Versatility in Proteo
2026-05-05
Unlock the power of Pronase E, a high-activity protease mixture, for advanced applications in protein sample preparation and molecular biology. Discover how recent mechanistic insights and unique solubility properties can elevate your proteomics workflows.
C-Terminal Src Kinase Inhibition Drives Ibrutinib-Induced AF
2026-05-05
This study illuminates the mechanism behind ibrutinib-induced atrial fibrillation (AF), demonstrating that off-target inhibition of C-terminal Src kinase (CSK), rather than Bruton tyrosine kinase (BTK), is responsible for increased AF risk. The findings have significant implications for the design of kinase inhibitors in both oncology and cardiovascular safety profiling.
ATRX Loss Sensitizes Glioma to Multi-Targeted RTK Inhibitors
2026-05-04
This study identifies ATRX-deficient high-grade glioma cells as particularly vulnerable to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors, suggesting a new stratification paradigm for targeted therapy. Incorporating ATRX mutation status may enhance the precision of clinical trial analyses for glioma treatments.
PAD4-IN-2 TFA: A Next-Generation PAD4 Inhibitor for Tumor-Se
2026-05-04
Explore how PAD4-IN-2 TFA, a selective PAD4 inhibitor, achieves tumor-targeted NET suppression and immune modulation. This article uniquely dissects its mechanistic advantages and translational value for cancer research.
Jasplakinolide: Actin Polymerization Inducer for Cell Dynami
2026-05-03
Jasplakinolide, offered by APExBIO, stands out as a high-affinity, membrane-permeable actin polymerization inducer for precise manipulation of the cytoskeleton. Its unique stabilization of F-actin enables advanced imaging, cytoskeletal dynamics studies, and antifungal research—empowering workflows from basic cell biology to translational assays.
Transcription Termination Mitigates DNA Damage After WEE1 In
2026-05-02
This study uncovers how transcription termination counters DNA damage following WEE1 inhibition by adavosertib, linking transcription-replication conflict management to cancer cell survival. The mechanistic insights inform strategies for exploiting replication stress and genome instability in targeted cancer therapies.
Nitric Oxide-Driven Nanomotors Enhance Glioblastoma Immunoth
2026-05-02
This study introduces a chemotactic nanomotor responsive to glioblastoma’s microenvironment, enabling precise drug delivery and robust immune activation. The approach addresses major barriers in brain tumor immunotherapy by leveraging microenvironmental gradients for targeted, multi-step intervention.
Asunaprevir (BMS-650032): Molecular Insights and Translation
2026-05-01
Explore the molecular mechanisms and translational applications of Asunaprevir (BMS-650032) as a potent NS3 protease inhibitor for hepatitis C virus research. This article delivers unique insights and practical guidance for advanced HCV RNA replication inhibition workflows.
Applied Epigenetic Profiling with 5-Azacytidine: Optimizing
2026-04-30
Unlock precise DNA demethylation and gene reactivation in cancer models using 5-Azacytidine (5-AzaC). Learn stepwise workflows, troubleshoot common pitfalls, and integrate the latest reference-backed protocols for robust epigenetic modulation in your research.
Nanocrystal Thermogel Delivery Enhances CDK4/6 Inhibitor Eff
2026-04-30
This study introduces a nanocrystal-integrated, thermoresponsive in situ gel platform for the local delivery of palbociclib, a CDK4/6 inhibitor, in breast cancer models. The approach significantly improves drug solubility, cellular uptake, and sustained release, resulting in enhanced anticancer activity and reduced systemic toxicity. These findings inform the design of advanced localized therapies and highlight the value of mitochondrial assays for mechanism-of-action studies.
CCG-1423: Unveiling RhoA Inhibition for Metastasis and Viral
2026-04-29
Discover how CCG-1423, a potent RhoA inhibitor, enables advanced research on metastasis and viral entry by disrupting MRTF-A/importin interactions. This article uniquely integrates cutting-edge virology findings with cancer research applications.
Tofacitinib Citrate Workflows: JAK3 Inhibition in Immune Res
2026-04-29
Tofacitinib citrate (CP-690550 citrate) empowers researchers to dissect JAK-STAT signaling and immune modulation with precision. This article delivers actionable protocol enhancements, comparative insights, and troubleshooting strategies to optimize your inflammatory disorder research using APExBIO’s trusted reagent.
466 records 20/32 page Previous Next First page 上5页 1617181920 下5页 Last page